-
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Bank of America Corporation (NYSE: BAC) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Nationally Recognized Firm Urges Bank of America Investors to Explore Class Action Representation
Lifestyle Content
Technology
-
Liberty CDJR to Auction All-Electric Dodge Charger Daytona for Philadelphia Youth
-
Excellence Appliance Repair Announces West Austin Location on Bee Caves Road
-
DirectCaseReview.com Launches an Online Platform to Help Car Accident Victims Learn What Their Case May Be Worth
-
KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
-
Dr. Sindhu Bhaskar Wins ‘Social Impact Champion’ at Influencer Magazine Awards 2026
Entertainment
-
Behind the Magic of Macy’s 100th Thanksgiving Day Parade: YVP Prepares to Welcome 1,300 Guests Along the Iconic Route
-
Distributed Ledger Technologies (DLT) Launches xCoin (XID) with Post-Quantum Security
-
Mango AI Brings AI Video Face Swap to Short Clips
-
30+ Years Fighting for Massachusetts’s Injured Workers: Attorney John J. Sheehan’s Bilingual Practice
-
Mike Bolger Receives Two Diamond Awards in Waterloo and Cambridge Readers’ Choice 2026
Health
-
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
-
Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
-
TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
-
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
-
HIMS Deadline: Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights
